ICD-10 Coding for Vancomycin Trough Monitoring(B95.61, B95.61B, B95.61M)
Learn about ICD-10 coding for vancomycin trough monitoring, including code Z51.81, documentation requirements, and common pitfalls.
Complete code families applicable to Vancomycin Trough Monitoring
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| Z51.81 | Encounter for therapeutic drug level monitoring | Use when documenting therapeutic drug monitoring without an active infection. |
|
| B95.61 | Methicillin resistant Staphylococcus aureus infection as the cause of diseases classified elsewhere | Use as primary code when treating MRSA infections with vancomycin. |
|
| T80.6 | Other serum reaction due to administration of blood or blood products | Use when documenting adverse effects like nephrotoxicity from vancomycin. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutVancomycin Trough Monitoring
Documentation & Coding Risks
Avoid these common issues when documenting Vancomycin Trough Monitoring.
Omitting infection code when monitoring vancomycin
Impact
Clinical: Misrepresentation of patient's treatment plan., Regulatory: Non-compliance with ICD-10 coding rules., Financial: Potential claim denials due to incomplete coding.
Mitigation
Always include primary infection code when applicable., Review documentation for completeness.
Using Z51.81 as primary for MRSA treatment
Impact
Reimbursement: Incorrect sequencing can lead to denied claims., Compliance: Non-compliance with ICD-10 sequencing rules., Data Quality: Inaccurate data on infection treatment.
Mitigation
Sequence B95.61 as primary for MRSA infections
Therapeutic Drug Monitoring Documentation
Impact
Inadequate documentation of trough levels can lead to audit issues.
Mitigation
Ensure complete documentation of timing and indication for monitoring.